Novo Nordisk's Main Europe Problem Is Reimbursement

May 1 (Bloomberg) -- Jesper Brandgaard, chief financial officer of Novo Nordisk A/S, discusses its Tresiba diabetes treatment, European Medicines Agency concerns about its diabetes treatment Victoza and challenges in the European market. He speaks from Copenhagen with Francine Lacqua and Caroline Hyde on Bloomberg Television's "On the Move." (Source: Bloomberg)

Full Show: Bloomberg Businessweek (03/24)
13:10 - Bloomberg Television takes you behind the scenes of our award-winning magazine "Bloomberg Businessweek." Hosts Carol Massar and Oliver Renick talk with the writers who break news on a weekly basis. (Source: Bloomberg)
  • S&P 500 Winners and Losers for 03/24
  • Full Show: Best of Bloomberg Markets Middle East (03/24)
  • How to Trade the Health Care Select Sector SPDR Fund